TIDMHIK

RNS Number : 9923I

Hikma Pharmaceuticals Plc

10 August 2023

Notification and public disclosure of transactions by persons discharging managerial responsibilities

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Bassam Kanaan 
 2    Reason for the notification 
 a)   Position/status           PDMR 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             Disposal of 25,000 of ordinary shares at 10 
       transaction               pence each in Hikma Pharmaceuticals PLC 
 c)   Price(s) and              Price(s): GBP21.71 
       volume(s)                 Volume(s):25,000 
 d)   Aggregated information 
        *    Volume 
                                 25,000 
                                 GBP21.71 
        *    Price               GBP542,750 
 
 
 
        *    Total 
 e)   Date of the transaction   08 August 2023 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Brian Hoffmann 
 2    Reason for the notification 
 a)   Position/status           PDMR 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             Disposal of 5,912 ordinary shares at 10 pence 
       transaction               each in Hikma Pharmaceuticals PLC. 
 c)   Price(s) and              Price(s): GBP22.05 
       volume(s)                 Volume(s):5,912 
 d)   Aggregated information 
        *    Volume 
                                 5,912 
                                 GBP22.05 
        *    Price               GBP130,359.60 
 
 
 
        *    Total 
 e)   Date of the transaction   09 August 2023 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction

Helen Middlemist, Deputy Company Secretary

+44 (0) 20 7399 2760

10 August 2023

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHBUGDIDUBDGXG

(END) Dow Jones Newswires

August 10, 2023 11:53 ET (15:53 GMT)

Hikma Pharmaceuticals (LSE:HIK)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024 Haga Click aquí para más Gráficas Hikma Pharmaceuticals.
Hikma Pharmaceuticals (LSE:HIK)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024 Haga Click aquí para más Gráficas Hikma Pharmaceuticals.